Amine solvate of sodium-glucose linked transporter inhibitor, and preparation method and application thereof

Crystal of 3'-sialyllactose sodium salt n-hydrate, and process for producing same

POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN

PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN

Solid state forms of Venetoclax and processes for preparation of Venetoclax

Crystalline form of compound suppressing protein kinase activity, and application thereof

PYRIMIDINE COMPOSITIONS, ULTRA-PURE COMPOSITIONS AND SALTS THEREOF, METHODS OF MAKING THE SAME, AND METHODS OF USING THE SAME FOR TREATING HISTAMINE H4 RECEPTOR (H4) MEDIATED DISEASES AND CONDITIONS

Crystals of quinazoline derivative and preparation method therefor

CRYSTAL POLYMORPHISM OF KCNQ2-5 CHANNEL ACTIVATOR

Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine

Method for the continuous manufacture of bisphenol A

Salt of fused heterocyclic derivative and crystal thereof

Crystalline polymorph of 15B-hydroxy-osaterone acetate

Squalamine solid forms and methods of making the same

TH-302 solid forms and methods related thereto

Process for preparing (4S)- 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide and purification thereof for use as a pharmaceutical active ingredient

Pyrimidine compound as JAK kinase inhibitor

Polymorphic form of crystalline rosuvastatin calcium and novel processes for crystalline as well as amorphous rosuvastatin calcium

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

Process for the preparation of tavaborole, its novel polymorphic forms and the polymorphs thereof

Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors

Crystal form of brexpiprazole and preparation method therefor

Crystalline forms and compositions of CFTR modulators

Crystalline form E of tafamidis meglumine, process for preparation and use thereof

Therapeutically active compounds and their methods of use

Oral care composition zinc-lysine complex

Crystal form of fludarabine phosphate, preparation method therefor, and application thereof

Salts of TAM inhibitors

Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide

Salts and crystals of ITI-007

Treatment of osteoarthritis

Process for the preparation of diphenylpyrazine derivatives

Polymorphic form of N-{6-(hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2H-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide

Pharmaceutical forms of diazabicyclooctane derivatives and manufacturing method thereof

Plinabulin compositions

Method for preparing the anhydrous crystalline form of isoniazid-derived hydrazone, thus produced crystalline polymorph of the anyhydrous form, use thereof for the treatment of alzheimer's disease, parkinsonism and other neurodegenerative disorders, and pharamceutical composition

Synthesis of indazoles

Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses

Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde

Physical form of a SGR modulator

COFORMER SALTS OF (2S,3S)-METHYL 7-FLUORO-2-(4-FLUOROPHENYL)-3-(1-METHYL-1H-1,2,4-TRIAZOL-5-YL)-4-OXO-1,2,3,4-TETRAHYDROQUINOLINE-5-CARBOXYLATE AND METHODS OF PREPARING THEM

NOVEL FORMS OF APREMILAST

Formulations of a PI3K/mTOR-inhibitor for intravenous administration

Polymorphic forms of sofosbuvir

Crystal form of tenofovir alafenamide salt, preparation method and use thereof

Polymorph of DPPIV inhibitor maleate and preparation method therefor

HYDROCHLORIDE SALT CRYSTAL OF DRUG FOR TREATING OR PREVENTING JAK-ASSOCIATED DISEASE AND PREPARATION METHOD THEREOF

Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereof

SOLID FORMS COMPRISING (1E, 4E)-2-AMINO-N,N-DIPROPYL-8-(4-(PYRROLIDINE-1-CARBONYL)PHENYL)-3H-BENZO[B]AZEPINE-4-CARBOXAMIDE, COMPOSITIONS THEREOF, AND USES THEREOF

CRYSTALLINE FORM

VINORELBINE MONOTARTRATE AND ITS PHARMACEUTICAL USE

Crystalline forms of diazabicyclooctane derivatives and production process thereof

Crystalline forms of (3-Amino-oxetan-3-ylmethyl)-[2-(5,5-dioxo-5,6,7,9-tetrahydro-5lambda*6*-thia-8-aza-benzocyclohepten-8-yl)-6-methyl-quinazolin-4-yl]-amine

Crystalline forms of mesylate salt of pyridinyl amino pyrimidine derivative, preparation methods therefor, and applications thereof

Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione hemihydrate, compositions and methods of use thereof

Crystalline 4-amino-2-(2,6-dioxopiperidine-3-YL)isoindoline-1,3-dione monohydrate, compositions and methods of use thereof

Crystalline form of Eluxadoline

Crystal forms of beta-nicotinamide mononucleotide

Solid forms of an HIV capsid inhibitor

Polymorph of pimavanserin tartrate and preparation method thereof and use of same

Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

Crystalline forms of therapeutic compounds and uses thereof

EGFR inhibitor free base or acid salt polycrystalline form, preparation method therefor, and application

Process for the preparation of Trisodium (4- {[1S,3R)-1-([1,1′-biphenyl]-4-ylmethyl)-4-ethoxy-3-methyl-4-oxobutyl]amino}-4-oxobutanoate)-(N-petanoyl-N-{[2′-(1H-tetrazol-1-1D-5-yl)[1,1′-biphenyl]-4-yl]methyl}- L-valinate) and its polymorphs thereof

Chlorhexidine crystal forms and uses thereof in medicine

Solid state forms of spiro-oxindole compounds

Crystal forms of palbociclib, and preparation method and use therefor

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

Solid state forms of Nilotinib salts

Crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione dihydrate, compositions and methods of use thereof

Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

Method and system for transporting inventory items

Method for producing 7h-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof

Process for the preparation of optically active Beraprost

Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride

D-proline derivatives as SAP depleting agent

Polymorphic form of TG02

Crystalline forms of (6-(1H-indazol-6-yl)-N-[4-(4-(4-morpholinyl)phenyl]imidazo[1,2-A]pyrazin-8-amine) methanesulfonate

Crystalline forms of a FGFR inhibitor and processes for preparing the same

Crystalline modifications of methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}phenyl)amino](phenyl)methylidene}-2-oxo-2,3-dihydro-1H-indole-6-carboxylate salts and methods of preparation thereof

Crystal of compound having JAK-inhibiting activity

Mercaptopurine hemihydrate

Crystalline forms

Anhydrate-free polymorphically pure micronized crystalline brexpiprazole di-hydrate for use in intramuscular injectable sustained release formulations

Modified process for the preparation of Ceritinib and amorphous form of Ceritinib

Trans-isomeric heterocyclic compounds and preparation thereof

Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt

Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

Zinc oxide complexes

CRYSTALLINE FORMS OF A MACROLIDE, AND USES THEREFOR

Crystalline forms of ethyl ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl(-L-alaninate

Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-D] pyrimidin-4-amine, preparation process and use thereof

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Sodium salt of uric acid transporter inhibitor and crystalline form thereof

Solid forms of an S-Nitrosoglutathione reductase inhibitor

CRYSTALLINE SALTS OF (4S,4AS,5AR,12AS)-4-DIMETHYLAMINO-3,10,12,12A-TETRAHYDROXY-7-[(METHOXY(METHYL)AMINO)-METHYL]-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-NAPHTHACENE-2-CARBOXYLIC ACID AMIDE AND METHODS OF USING THE SAME

CHEMICAL COMPOUNDS

Polymorphs

Salt form of DPPIV inhibitor and preparation method thereof

Quantification and preparation of pharmaceutical grade cantharidin

TLR7 agonist trifluoroacetate salt and crystalline form B thereof, preparation methods and uses

Processes for producing diazabicyclooctane compounds

Formulations of a compound modulating kinases

Pharmaceutical composition comprising sacubitril and valsartan

Substituted tetrahydrocarbazole and carbazole carboxamide compounds

Polymorphs of dolutegravir and salts thereof

PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-alpha]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF

Solid forms of Selinexor and process for their preparation

Solid state forms of N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide and process for preparation thereof

Crystalline forms of a prolyl hydroxylase inhibitor

Mechanically interlocked air-stable radicals

Process for making beta 3 agonists and intermediates

Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations

Salts of morpholine derivative, crystal forms thereof, processes for producing the same, pharmaceutical compositions including the same, and use thereof

Powdery 1,4-cyclohexanedicarboxylic acid

CRYSTALLINE FORMS OF (2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO[1',2':4,5]PYRAZINO[2,1-B][1,3]OXAZEPINE-10-CARBOXAMIDE

Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredient

Crystalline form of BTK kinase inhibitor and preparation method thereof

Salt of quinolone compound, polymorphs thereof, preparation method therefor, composition, and applications

Process for making crystalline form a of gefitinib

Crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-piperidin-1-yl)-propenone

Process for the preparation of apremilast

Crystalline forms

Crystalline Form Of Ticagrelor

Crystalline forms of ibrutinib

Polymorph of Riociguat and its process for the preparation

Crystallization procedure for obtaining canagliflozin hemihydrate crystals

CRYSTALLINE FORMS OF VILAZODONE HYDROCHLORIDE AND VILAZODONE FREE BASE

Crystals of quinazoline derivative and preparation method therefor

Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts

Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

Preparation of latanoprostene bunod of desired, pre-defined quality by gravity chromatography

Crystalline form A of rebaudioside D, and preparation method and application therefor

Crystal form of substituted aminopyran derivativek

Solid Oral Formulations and Crystalline Forms of an Inhibitor of Apoptosis Protein

Therapeutically active compounds and their methods of use

P-TOLUENESULFONATE FOR MEK KINASE INHIBITOR, METHOD OF PREPARATION THEREOF, AND METHOD OF USE THEREOF

PROCESS OF PREPARING TYROSINE KINASE INHIBITOR

Solabegron zwitterion and uses thereof

Gamma-aminobutyric acid hemihydrate crystal and preparation method thereof

2-(3-ethanesulfonylpyridine-2-yl)-5-(trifluoromethanesulfonyl) benzoxazole crystal

CRYSTALLINE AND AMORPHOUS FORMS OF CARFILZOMIB

Crystalline forms of a Bruton's tyrosine kinase inhibitor

Crystalline forms of a Bruton's tyrosine kinase inhibitor

CRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR

Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide and methods of their use

Process for the preparation of aclidinium bromide

Inhibiting agents for Bruton's tyrosine kinase

Forms and compositions of an ERK inhibitor

Method of preparing (3R,4S)-3-acetamido-4-allyl-N-(tert-butyl)pyrrolidine-3-carboxamide

Process for the preparation of enclomiphene citrate having needle shaped crystal habit

Crystalline polymorphs of 1,6-dibromo-1,6-dideoxy-dulcitol

Crystalline solvate comprising 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile, methanol, N-N-dimethylformamide, and water

Solvated crystal form of rifaximin, production, compositions and uses thereof

Solid forms of (Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid

Crystalline forms of (S)-afoxolaner

Preparation method for eutectic hydrate crystal form II of AHU-377 and diovan trisodium salt

Method and system for transporting inventory items

Piperidin-4-yl azetidine derivatives as JAK1 inhibitors

METHOD FOR PREPARING SOFOSBUVIR CRYSTAL FORM-6

Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5- (4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate

Chlorosilylarylgermanes, method for preparation thereof and use thereof

Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratio

Crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]methanone

Crystal of a heterocyclidene acetamide derivative

CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM

POLYMORPHIC FORMS OF SODIUM BENZOATE AND USES THEREOF

POLYMORPHS AND SOLID FORMS OF (S)-2-((2-((S)-4-(DIFLUOROMETHYL)-2-OXOOXAZOLIDIN-3-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)AMINO)PROPANAMIDE, AND METHODS OF PRODUCTION

5-methyl-1,3,4-oxadiazol-2-yl compounds

Polymorphic forms of minocycline base and processes for their preparation

Crystals of thiadiazole derivative DPP-IV inhibitors and uses thereof

SUBSTANTIALLY PURE VEMURAFENIB AND ITS SALTS

Process for the preparation of pure nilotinib and its salt

Process for synthesis of lenalidomide

Crystallization method and bioavailability

Crystalline forms of a Bruton's tyrosine kinase inhibitor

Crystalline forms of (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide

3-methyl-pyrrolidine-2,5-dione derivatives useful as CGRP receptor antagonists

Process for the preparation of crystalline dexlansoprazole

Process and novel polymorphic form of Apremilast

Crystal of monovalent cation salt of 3-hydroxyisovaleric acid and process for producing the crystal

NOVEL COMPOUNDS

Co-crystals and pharmaceutical compositions comprising the same

Crystalline forms of a bruton's tyrosine kinase inhibitor

CRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR

Salt and polymorphic forms of (3R,4S)-L-((4-amino-5H-pyrrolo[3,2,-D]pyrimidin-7-yl)methyl)-4(methylthiomethyl)pyrodin-3-ol(MTDIA)

Pyrido[1,2-A]pyrimidone analog, crystal form thereof, intermediate thereof and preparation method therefor

Pyrroloquinoline quinone B crystal form and preparation method therefor

EGFR inhibitor and pharmaceutically acceptable salt and polymorph thereof, and use thereof

CO-CRYSTALS OF BENZIMIDAZOLE COMPOUNDS

Thermodynamically stable crystal modification of 2-methyl-N-(5-methyl-1, 3, 4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide

2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof

CYCLOSPORIN A FORM 2 AND METHOD OF MAKING SAME

Crystal form, preparation method and intermediate of dihydropyrido ring compound

Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making same

Polymorphic forms of Afatinib free base and Afatinib dimaleate

KDM1A inhibitors for the treatment of disease

Quinazolin crotyl compound dimaleate crystals and preparation methods and uses thereof

Heat-sensitive recording material and diphenylsulfone

Preparation and Uses of Obeticholic Acid

Crystal of 6′-sialyllactose sodium salt, and process for producing same

Pharmaceutical compositions of compound

Crystal form A of 7-(cyclopropylmethyl)-1-((()-4-hydroxy-4-methylcyclohexyl)methyl)-3-methyl-1H-purine-2,6-(3H,7H)-dione for treating liver diseases

1, 3, 4-thiadiazole compounds and their use in treating cancer

DTPA PRODRUGS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME

Acetylsalicylic acid derivative crystal, its preparation method and use

Polymorphic forms of naltrexone

Processes for preparing ACC inhibitors and solid forms thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Inhibiting agents for bruton's tyrosine kinase

CRYSTAL FORM OF QUINOLINE COMPOUND AND PROCESS FOR ITS PRODUCTION

PROCESS FOR PREPARING A DIAMINE/DICARBOXYLIC ACID SALT

Preparation of and formulation comprising a MEK inhibitor

Sacubitril calcium salts

Crystalline Forms of Fosnetupitant

POLYMORPHOUS FORMS OF RIFAXIMIN, PROCESSES FOR THEIR PRODUCTION AND USE THEREOF IN THE MEDICINAL PREPARATIONS

Fumagillol derivatives and polymorphs thereof

Stable crystal form of tipiracil hydrochloride and crystallization method for the same

Inhibitors of Bruton's tyrosine kinase

CRYSTALLINE SOLID FORMS OF THE ACETATE SALT OF (1S,3S,4R)-4-((3AS,4R,5S,7AS)-4-(AMINOMETHYL)-7A-METHYL-1-METHYLENEOCTAHYDRO-1H-INDEN-5-YL)-3-(HYDROXYMETHYL)-4-METHYLCYCLOHEXANOL

PYRAZOLOPYRIMIDINE COMPOUNDS

Pharmaceutical co-crystal and use thereof

Reversible Continuous Variable Chromogenic Material, Preparation Method and Application thereof

Crystalline and amorphous forms of 17-alpha-hydroxyprogesterone caproate

Crystal forms of β-nicotinamide mononucleotide

Amorphous Ixazomib Citrate

Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt

PROCESS FOR THE PREPARATION OF THE AMORPHOUS FORM OF IBRUTINIB AND NOVEL CRYSTALLINE FORM

Hydrochloride salt form for EZH2 inhibition

FORMS AND COMPOSITIONS OF BIARYL INHIBITORS OF BRUTON'S TYROSINE KINASE

Crystal form of a potassium-competitive acid blocker and preparation method thereof

(S)-CSA salt of S-ketamine, (R)-CSA salt of S-ketamine and processes for the preparation of S-ketamine

1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID POLYMORPHS

Highly crystalline spherical silk fibroin micro-particles and a process for preparation thereof

CRYSTAL FORM OF PYRROLOQUINOLINE QUINONE SODIUM SALT AND PREPARATION METHOD AND USE THEREOF

Salts and solid forms of a monobactam antibiotic

CRYSTAL FORMS OF A M1 RECEPTOR POSITIVE ALLOSTERIC MODULATOR

Methods for purification of non-psychoactive isoprenoid compounds from biological extracts

SALTS AND SOLID STATE FORMS OF VORTIOXETINE

Amorphous trisodium sacubitril valsartan and a process for the preparation thereof

Process for the Preparation of Eltrombopag Olamine

Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders

Polymorphic forms of pitavastatin sodium

Crystalline forms of tenofovir alafenamide

Process for the preparation of dipeptidyl peptidase-4 (DPP-4) enzyme inhibitor

Crystal form of neratinib maleate and preparation method therefor

Antifungal compounds and processes for making

Polymorphic compounds and uses thereof

Crystalline forms of a PI3K inhibitor

Salt type and crystal type of 4H-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereof

TYK2 inhibitors, uses, and methods for production thereof

DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS

Process for the preparation of Daclatasvir dihydrochloride and its intermediates

NEW CRYSTAL OF PIPERAZINE COMPOUND

Antifungal compound process

SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES

Solid forms of substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds

Process for preparation and purification of Sugammades sodium

Inhibitors of bruton'S tyrosine kinase

Ibrutinib solid forms and production process therefor

DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON'S TYROSINE KINASE

1-(4-(2-((1-(3,4-difluorophenyl)-1H-pyrazol-3-Yl)methoxy)ethyl)piperazin-1- Yl)ethanone salts

CRYSTAL FORM OF FLUDARABINE PHOSPHATE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

Phosphoramidate compound and preparation method and crystal thereof

METHODS OF TREATING A FATTY ACID AMIDE HYDROLASE-MEDIATED CONDITION

Polymorphic forms and co-crystals of a c-Met inhibitor

Purinone derivative hydrochloride

Process for the preparation of amorphous (1S)-1,5-anhydro-1-[3-[[5-(4 fluorophenyl)-2-thienyl]-4-methylphenyl]-D-glucitol and its polymorphs thereof

Pyridine substituted 2-aminopyridine protein kinase inhibitor crystal

Crystals of 5-cyclopropyl-2-((1-(3-fluorobenzyl)-1H-indol-5-yl)amino)nicotinic acid

Crystalline form of androgen receptor inhibitor and preparation method thereof

Process for the preparation of the compound N-(3,5-dimethylphenyl)-N′-(2-trifluoromethylphenyl) guanidine

Medical use of compound III

Chemical compounds

Crystal form of bisulfate of JAK inhibitor and preparation method therefor

Process for preparing AG-10, its intermediates, and salts thereof

Acetate salt of buprenorphine and methods for preparing buprenorphine

Crystalline form of lorlatinib free base

[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseases

Inhibiting the transient receptor potential A1 ion channel

Hydroxyethyl sulfonate of cyclin-dependent protein kinase inhibitor, crystalline form thereof and preparation method therefor

MULTICOMPONENT CRYSTALS OF DASATINIB WITH MENTHOL OR VANILLIN

Crystal form of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxole-5-yl)cyclopropane formamido)-3-methylpyridine-2-yl)benzoic acid and preparation method thereof

Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride

Methods of synthesizing thyroid hormone analogs and polymorphs thereof

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

Co-crystals of substituted glycine and uses thereof

Co-crystals of substituted glycine and uses thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

LEVALBUTEROL SALT

Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus

Processes for preparing an FGFR inhibitor

5-methyl-1,2,4-oxadiazol-3-yl compounds

Salts of quinazoline derivative or crystals thereof, and the process for producing thereof

Polymorphs of Selinexor

Solid state forms of netarsudil mesylate

CRYSTALLINE SOLVATE FORMS OF A PHARMACEUTICAL

STABLE CRYSTALLINE FORM OF REGADENOSON